A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • Events
  • Conference: FT Global Pharmaceutical and Biotechnology Co...
Conference - Event date: 08 Nov 2021
Share

FT Global Pharmaceutical and Biotechnology Conference

On Monday 8 November 2021, Margo Warren will join the Financial Times' virtual Global Pharmaceutical and Biotechnology Conference to discuss pharma pipelines.

Explore further

News

Investors issue urgent call for “fair and equitable” global response to COVID-19

Today, almost 150 institutional investors have issued a joint call for a fair and equitable global response to the pandemic, including through fully financing the ACT Accelerator partnership dedicated to developing, producing and ensuring equitable access to COVID-19 tools. 

The signatories, which together manage or advise on assets worth more than USD 14 trillion, have also committed to engage with healthcare companies to promote bolder industry actions and therefore contribute to ending the pandemic. The initiative has been coordinated by the Access to Medicine Foundation, as part of its ongoing engagement work with investors. 
Media

Margo Warren on BBC: ACT-Accelerator and the need for medical oxygen access in LMICs

In this episode of BBC Newshour, the daily current affairs programme on the BBC World Service, Margo Warren joins host Julian Marshall to discuss the pressing medical oxygen crisis in India and many LMICs.
Publication

Fortune: Gasping for breath: Covid-19 exposes medical oxygen crisis and need for industry action

In this viewpoint for Fortune Magazine, Access to Medicine Foundation Executive Director Jayasree K. Iyer addresses the urgent need for medical oxygen in low- and middle-income countries (LMICs), examining the role of pharmaceutical companies and how existing needs amplified due to COVID-19.

Get in touch

Back to top |